Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2009
07/09/2009CA2708273A1 Methods of improving genetic profiles of dairy animals and products
07/08/2009EP2077330A1 Transgenic pig with altered incretin function and its uses for studying diabetes
07/08/2009EP2077329A1 Transgenic pig with altered incretin function
07/08/2009EP1301592B1 Recombinant bacterial phytases and uses thereof
07/08/2009CN201267151Y Device for cultivating Bursaphelenchus nematodes
07/08/2009CN201267150Y Environment friendly ecological cultivation island
07/08/2009CN101473808A Artificial culture, breeding and preservation method of plant root-knot nematode
07/08/2009CN101473807A Seed production method of dwarf broiler chicken with deep-color leg
07/07/2009USRE40831 Passive immunotherapy; hybridoma cell line and antibodies produced by the cell lines; prevention and treatment of HBV infection
07/07/2009US7557258 useful to elucidate the function of TIR domain-containing TRIF-related adaptor molecule (TRAM); and a method for screening substances regulating responses to ligands recognized by Toll-like receptors 4 (TLR4) with the transgenic mouse
07/07/2009US7557196 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
07/07/2009US7557083 Gastrokines and derived peptides including inhibitors
07/07/2009US7556964 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals
07/07/2009US7555866 Renewably buoyant, self-protective floating habitat
07/02/2009WO2009081977A1 Infected nail of animal infected with fungus
07/02/2009WO2009081976A1 Animal infection model for microbial infection
07/02/2009WO2009080864A1 Method for the production of fish progeny
07/02/2009WO2008104807A3 Mite composition
07/02/2009WO2007134876A8 HIGH AFFINITY HUMAN AND HUMANIZED ANTI-α5β1 INTEGRIN FUNCTION BLOCKING ANTIBODIES WITH REDUCED IMMUNOGENICITY
07/02/2009US20090172827 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
07/02/2009US20090172826 Model System for TCR (ZETA) Chain Downregulation
07/02/2009US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
07/02/2009US20090170165 Method for recombinant production in cho cells
07/02/2009US20090170122 Human intestinal NPT2B
07/02/2009US20090170099 Use of Regulatory Sequences for Specific, Transient Expression in Neuronal Determined Cells
07/02/2009US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
07/02/2009US20090170067 Simian tropic, recombinant human immunodeficiency-1 viruses
07/02/2009US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
07/02/2009US20090169540 Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy
07/02/2009US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
07/02/2009US20090165723 Methods of producing avian eggs and birds of specified germ-free status
07/01/2009EP1648224B1 Rat model of diabetic nephropathy
07/01/2009EP1551222B1 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny
07/01/2009EP1315417B1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
07/01/2009EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon
07/01/2009CN101472470A Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in miR155 transgenic mice
07/01/2009CN101469329A Compositions and methods for increasing bone mineralization
07/01/2009CN100506070C Cultivation of DHA-rich prey organisms containing rich docosahexenoic acid for aquatic species
07/01/2009CN100506030C Artificial breeding method for schizothorax
06/2009
06/30/2009US7554008 Having higher activity for omega-3 fatty acids than omega-6 fatty acids, of given sequences; increasing polyunsaturated fatty acid (PUFA) content; vectors; transgenic plants, animals
06/30/2009US7554004 Allelic series of genomic modifications in cells
06/30/2009US7554003 transgenic Drosophila whose genome is homozygous for the loechrig (loe) allele and for the Drosophila beta-amyloid precursor-like deletion allele; enhanced vacuolization, sterility in female Drosophila, neurodegeneration, accumulation of fatty acids in the brain; reduction of cholesterol ester; Alzheimer
06/30/2009US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma
06/25/2009WO2009077618A2 A host cell deficient for murf1 and murf2
06/25/2009WO2009034158A3 Transgenic mice
06/25/2009US20090165155 Tissue Specific Expression of Exogenous Proteins in Transgenic Chickens
06/25/2009US20090165154 Genetically engineered ungulates for use as bioreactors for human antibodies; reducing transmission of spongiform encephalopy
06/25/2009US20090165153 Modified gene-silencing RNA and uses thereof
06/25/2009US20090165152 Mesothelin Vaccines and Model Systems
06/25/2009US20090165151 Canine transient receptor potential v2 (ctrpv2) and methods of screening for trpv2 channel modulators
06/25/2009US20090165150 Directed complementation with removable gene of interest
06/25/2009US20090162848 Noxin, a novel stress-induced gene involved in cell cycle and apoptosis
06/25/2009US20090162455 Feed for fish
06/25/2009US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon
06/25/2009CA2708751A1 Gender-specific separation of sperm cells and embryos
06/24/2009EP2072528A1 A host cell deficient for MuRF1 and MuRF2
06/24/2009EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal
06/24/2009CN101461348A Device for cultivating lower animal with function for switching between air inflation and water feed
06/24/2009CN101461347A Industrialized semi-dry and semi-wet solid device for cultivating lower animal
06/24/2009CN101461346A Insect-imitating dynamic device for feeding wood frog
06/24/2009CN101461345A Intensive style method for hatching RanaspinosaDavid
06/24/2009CN100502644C Method for raising rabbits
06/23/2009US7550650 Production of a transgenic avian by cytoplasmic injection
06/23/2009US7550649 Transgenic non-human mammal
06/23/2009US7550648 Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein
06/23/2009US7550647 Transfected shrimp as production systems for therapeutic proteins
06/23/2009US7549391 Insect habitat and retail receptacle
06/18/2009WO2009075301A1 Small experimental animal imager
06/18/2009WO2009074702A1 Device and method for the mass culture of insect larvae
06/18/2009WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease
06/18/2009US20090158451 Indoleamine 2,3-Dioxygenase-2
06/18/2009US20090158450 Method for the transfer of episomal vectors into animal cells
06/18/2009US20090158449 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof
06/18/2009US20090158448 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
06/18/2009US20090158447 TLR ligand and IL-1 Response-Injured Animal Model
06/18/2009US20090156530 Norepinepherine Transporter Mutants and Uses Thereof
06/18/2009US20090156467 Thymic stromal lymphpoietin promoter and use therefor
06/18/2009US20090155846 Kinase anchor protein muteins, peptides thereof and related methods
06/18/2009US20090155806 identifying biallelic markers of a FLAP gene and the association established between these markers and diseases involving the leukotriene pathway such as asthma
06/18/2009US20090155280 Immunoglobulin Cleavage Fragments as Disease Indicators and Compositions for Detecting and Binding Such
06/18/2009US20090155276 NOVEL DKKL-1 Splice Product Modulators for Cancer Diagnosis and Therapy
06/18/2009US20090155243 Non-human model of autoimmune disease
06/18/2009US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them
06/18/2009US20090155174 RNA Interference Mediating Small RNA Molecules
06/18/2009CA2708992A1 Water treatment system
06/17/2009EP2069490A2 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
06/17/2009EP2069489A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
06/17/2009EP2068939A2 Methods of screening agents for activity using teleosts
06/17/2009EP2068618A2 Compositions and methods for cancer gene discovery
06/17/2009EP1943263A4 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors
06/17/2009CN101455192A Bdelloid rotifers mass culture method
06/17/2009CN101455191A Turtle alimentary canal disease control method and therapy medicine
06/17/2009CN101455190A Aphidius gifuensis Ashmaed scale propagation technique
06/17/2009CN101455189A New technological flow of cattle farm parasitic disease
06/17/2009CN100500658C Pharmaceutical composition of male sexual dysfunction
06/17/2009CN100499999C Wild pig breeding fodder formula
06/16/2009US7547817 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen
06/16/2009US7547816 Genetically engineered, galactosyltransferase deficient, pigs for use as source of organs, tissues and cells for xenotransplantation
06/16/2009US7547547 Bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor
06/16/2009US7547522 Genetic manipulation of nonhuman animals to be used for xenotransplantation; null swine; obtaining a line of cells from a GGTA1 heterozygous swine, enriching them by treatment with agents that specifically bind alpha (1,3)-galactose epitope and deplete cells that do not, scanning for viable cells